您现在的位置: 首页> 研究主题> 肝源性溃疡

肝源性溃疡

肝源性溃疡的相关文献在1992年到2020年内共计206篇,主要集中在内科学、药学、外科学 等领域,其中期刊论文201篇、会议论文5篇、专利文献109417篇;相关期刊135种,包括岭南急诊医学杂志、中国综合临床、临床消化病杂志等; 相关会议5种,包括中华中医药学会脾胃病分会第二十三次全国脾胃病学术交流会、第十二届全国感染药学学术会议暨第二届肝病治疗进展与临床药学学术研讨会、2006年全国药物警戒与临床合理用药学术会议等;肝源性溃疡的相关文献由398位作者贡献,包括乔冠恩、周立君、孙韬等。

肝源性溃疡—发文量

期刊论文>

论文:201 占比:0.18%

会议论文>

论文:5 占比:0.00%

专利文献>

论文:109417 占比:99.81%

总计:109623篇

肝源性溃疡—发文趋势图

肝源性溃疡

-研究学者

  • 乔冠恩
  • 周立君
  • 孙韬
  • 张文娟
  • 焦建中
  • 董魁
  • 陈德娇
  • 于庆功
  • 付春香
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 朱琳; 王中平; 王朝阳; 马立东; 董魁; 张文娟; 王军; 乔冠恩
    • 摘要: 目的 观察雷贝拉唑联合枸橼酸铋钾治疗肝源性溃疡的疗效.方法 对80例肝源性溃疡患者随机分组,治疗组用雷贝拉唑加枸橼酸铋钾,对照组单用雷贝拉唑.结果 雷贝拉唑联合枸橼酸铋钾组治愈率及有效率均优于单用雷贝拉唑组,差异有统计学意义(P<0.05).结论 雷贝拉唑联合枸橼酸铋钾治疗肝源性溃疡疗效好,加用胃黏膜保护剂有利于肝源性溃疡的愈合.
    • 乔冠恩; 孔洪彬; 王敏; 李亮亮; 王军; 董魁; 张文娟
    • 摘要: 目的 观察雷贝拉唑联合阿莫西林、左氧氟沙星根除幽门螺杆菌感染治疗对肝源性溃疡的疗效.方法 对60例幽门螺杆菌阳性肝源性溃疡患者随机分组,治疗组用雷贝拉唑加阿莫西林、左氧氟沙星,对照组单用雷贝拉唑.结果 雷贝拉唑联合阿莫西林、左氧氟沙星组幽门螺杆菌根除率及溃疡愈合有效率均优于单用雷贝拉唑组,差异有统计学意义(P<0.05).结论 雷贝拉唑联合阿莫西林、左氧氟沙星治疗肝源性溃疡疗效好,根除幽门螺杆菌有利于肝源性溃疡的愈合.
    • 朱砂
    • 摘要: 目的:研究慢性肝病合并消化性溃疡(HU)的临床特征、形成原因以及发病机理.方法:选择了我院250例慢性肝病患者作为研究对象,通过使用胃镜检查、幽门螺杆菌(HP)检测的方法进行研究.结果:HU的出现率是29.2%(73/250),当中以胃溃疡所占比例较高,占比为69.9%(51/73);有84.9%(62/73)的HU患者并没有出现典型的消化性溃疡有关的病征;通过幽门螺杆菌对HU患者进行检测,其检出率可以达到72.6%(53/73)结论:HU属于慢性肝病当中的一种比较常见的并发症,同时属于一种特殊的溃疡,其本身并没有普通群体消化性溃疡的特征;当中的病因以及发病机制现时也未能明确清楚,很有机会是由于和肝病相关的胃黏膜攻击因子提高与防御因子降低等多种原因共同作用最终导致的结果.
    • 李彤; 荣阳; 荣根满
    • 摘要: 目的 研究分析洛赛克治疗肝源性溃疡的效果与临床意义.方法 随机选择肝源性溃疡患者76例,其中除12例合并溃疡出血患者口服洛赛克20 mg每天2次,1周后改为20 mg每天1次外,其余患者均用洛赛克20 mg每天1次口服.结果 本组76例,上腹部疼痛3 d内的缓解率为63.6%,平均腹痛缓解时间为5.13 d.溃疡2周愈合率为76.3%,4周愈合率为94.2%,有效率为100%.结论 洛赛克对于肝源性溃疡的治疗效果显著,值得临床上推广应用.
    • 陈文彬
    • 摘要: Objective To investigate the expression of vascular endothelial growth factor(VEGF) and basic fibroblast growth factor(bFGF) in gastric mucosa of patients with hepatogenic ulcer,and to analysis the relationship between them and the incidence of complications and disease progression in patients.Methods During July 2014 to May 2016,133 cases of patients with hepatocir rhosis and portal hypertension associated with gastric or duodenal ulcer were selected as study object.Marginal tissue of ulcer were collected,and normal mucosa tissue were collected as control group.Reverse transcription-polymerase chain reaction(RT-PCR) detect the expression of VEGF mRNA and bFGF mRNA in 133 cases of normal gastric mucosa and 133 cases of marginal tissue of ulcer,including 52 cases of gastric ulcer activity period(GA),45 cases of gastric ulcer healing period(GH) and 36 cases of gastric ulcer scar period(GS).Spearman correlation coefficient analysis the correlation between the expression of VEGF mRNA and bFGF mRNA and complication rate.Results The expression of VEGF mRNA and bFGF mRNA in ulcer marginal tissues was significantly higher than that in normal mucosa tissues,the difference was statistically significant(P<0.05).The expression of VEGF mRNA in GH and GS of patients was significantly higher than that in GA patients,the difference was statistically significant (P<0.05),the expression of bFGF mRNA in GS of patients was significantly higher than that of GA patients,the difference was statistically significant(P<0.05).Spearman correlation analysis showed VEGF mRNA and bFGF mRNA was negatively correlated with incidence rate of ulcer complications (rs=-0.672,-0.508,P<0.05).Conclusion bFGF mRNA and VEGF mRNA may play an important role in the repair of hepatogenic ulcer.It is a potential clinical marker.%目的 探究肝源性溃疡中胃黏膜组织血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(bFGF)的表达,分析其与病情进展及患者并发症发生率的关系.方法 临床选取2014年7月至2016年5月133例肝硬化伴门静脉高压合并胃或十二指肠溃疡患者,内镜下活检溃疡边缘及正常黏膜组织为对照.采用反转录聚合酶链反应(RT-PCR)技术检测正常胃黏膜(133例)、胃溃疡活动期(GA期52例)、胃溃疡愈合期(GH期45例)、胃溃疡瘢痕期(GS期36例)患者黏膜组织VEGF mRNA、bFGF mRNA的表达情况,并与患者的并发症发生率行Spearman秩相关分析.结果 溃疡边缘组织VEGF mRNA、bFGF mRNA的表达量显著高于正常黏膜组织,差异有统计学意义(P<0.05);GH、GS期患者VEGF mRNA的表达量明显高于GA期患者,差异有统计学意义(P<0.05),GS期患者bFGF mRNA的表达量明显高于GA期患者,差异有统计学意义(P<0.05);Spearman秩相关分析结果示VEGF mRNA、bFGF mRNA的表达量与患者溃疡并发症发生率呈负相关(rs=-0.672,-0.508,P<0.05).结论 VEGF mRNA、bFGF mRNA在肝源性溃疡的修复过程中可能发挥重要的促进作用,是潜在的临床标志物.
    • 何永康; 袁雪梅
    • 摘要: 目的:探讨乙型肝炎肝硬化合并上消化道出血与幽门螺杆菌(HP)感染的关系,为临床诊疗提供理论依据.方法:选取2011年1月至2015年1月就诊于本院的乙型肝炎肝硬化合并上消化道出血者87例,根据患者年龄所在的区段将其分为A组(40 ~50岁)、B组(51~60岁)、C组(大于60岁)3组,均采用碳14呼气试验对所有患者进行HP感染检测,观察3组患者HP检测的阳性率及不同性别、不同肝功能级别以及不同类型的乙型肝炎肝硬化上消化道出血组间HP感染阳性率的差异.结果:87例乙型肝炎肝硬化合并上消化道出血患者中,55例(63.2%)HP检测阳性,男、女性的感染阳性率分别为64.2%和61.8%,差异无统计学意义(P>0.05);A组患者18例(50.0%)HP检测阳性,B组患者21例(70.0%)阳性,C组患者16例(76.2%)阳性,患者随着年龄的增大,HP检测的阳性率逐渐升高,且C组与A、B两组比较,差异有统计学意义(P<0.05),A、B两组间比较,差异无统计学意义(P>0.05);乙型肝炎肝硬化合并门脉高压性胃病出血患者HP阳性5例(31.2%),乙型肝炎肝硬化合并食管胃静脉曲张破裂出血患者HP阳性15例(71.4%),乙型肝炎肝硬化合并消化道溃疡出血患者32例(82.1%)阳性,乙型肝炎肝硬化合并原因不明出血患者3例(27.3%)阳性,乙型肝炎肝硬化合并消化道溃疡出血患者的HP感染率最高,但与乙型肝炎肝硬化合并食管胃静脉曲张破裂出血比较,差异无统计学意义(P>0.05),乙型肝炎肝硬化合并食管胃静脉曲张破裂出血和消化道溃疡出血的幽门螺杆菌检测阳性率明显高于乙型肝炎肝硬化合并门脉高压性胃病出血和原因不明出血,差异有统计学意义(P <0.05);Child-Pugh分级肝功能A级患者HP检测30例(63.8%)阳性,B级患者14例(60.9%)阳性,C级患者11例(64.7%)阳性,三种级别肝功能的乙型肝炎肝硬化合并上消化道出血幽门螺杆菌检测阳性率无明显差异(P>0.05).结论:HP感染与乙型肝炎肝硬化合并上消化道出血关系密切,根治HP感染,是乙型肝炎肝硬化上消化道出血的一项有效的预防措施.%Objective:To explore the relationship between Hepatitis B cirrhosis combined upper gastrointestinal hemorrhage and the helicobacter pylori infection.Methods:87 cases of hepatitis B cirrhosis combined upper gastrointestinal bleeding were collected from January 2011 to January 2011 in our hospital.The patients were divided into group A (40 to 50 years old),group B (51 to 60 years old),three group (> 60 years) according to the age.Helicobacter pylori infection were tested through carbon 14 breath test for all groups,and the positive rate of Helicobacter pylori detection and the difference of positive rate of HP infection among different sex,different liver function levels and different types of hepatitis B cirrhosis and upper gastrointestinal bleeding group also tested amoung three groups.Results:The positive rates of Helicobacter pylori was 55 cases (63.2%),while,64.2% and 61.8% respectively in males and females (P > 0.05);The case of HP positive was 18 (50%),21 (70%) and 16 (76.2%) in A,B,C group respectively.With the increase of age,the positive rate of HP detection increased gradually in the three groups,and the difference between the C group and the A group and the B group was statistically significant (P < 0.05),and there was no significant difference between the two groups (P > 0.05) in A and B group;The number of positive of HP in Hepatitis B hepatocirrhosis with portal hypertension gastropathy hemorrhage sex was5 cases (31.2%);while,hepatitis B cirrhosis combined esophageal gastric varices rupture hemorrhage was 15 cases (71.4%);hepatitis B cirrhosis combined digestive tract ulcer bleeding was 32 (82.1%);hepatitis B cirrhosis combined unexplained bleeding was 3 (27.3%).The rate of HP infection was biggest in hepatitis B cirrhosis combined digestive tract ulcer bleeding,but hepatitis B cirrhosis combined esophageal and gastric varices rupture hemorrhage has no statistically significant difference (P > 0.05);hepatitis B cirr hosis combined esophageal gastric varices rupture hemorrhage and digestive tract ulcer bleeding helicobacter pylori detection were significantly higher than hepatitis B,hepatocirrhosis with portal hypertension gastropathy hemorrhage and unexplained bleeding,the difference was statistically significant (P < 0.05);Child-Pugh class liver function was A HP positive detection of 30 patients (63.8 %),grade B 14 cases (60.9%) were positive,C grade 11 cases (64.7 %) were positive,three levels of liver function of hepatitis B cirr hosis combined upper gastrointestinal bleeding helicobacter pylori detection rate of no significant difference (P > 0.05).Conclusion:HP infection was closely related to upper gastrointestinal bleeding in patients with hepatitis B and cirrhosis.Radical HP infection was an effective preventive measure for upper gastrointestinal bleeding of hepatitis B cimhosis.
    • 贾昊鹍; 王正根
    • 摘要: 肝源性溃疡是指在肝硬化基础上出现的消化性溃疡,是肝硬化患者上消化道出血的常见原因,其发病率较单纯消化性溃疡者高.目前肝源性溃疡发病机制尚未完全明确,可能是门脉高压、肝功能不全等多种因素共同影响发展而成的.因存在肝硬化的基础,肝源性溃疡的治疗除抗溃疡治疗外,还需考虑原发病的治疗,治疗上存在一定的难度.本文结合国内外的研究结果,对肝源性溃疡的发病机制及药物治疗特点予以综述.
    • 贾昊鹍; 王正根
    • 摘要: 肝源性溃疡是指在肝硬化基础上出现的消化性溃疡,是肝硬化患者上消化道出血的常见原因,其发病率较单纯消化性溃疡者高。目前肝源性溃疡发病机制尚未完全明确,可能是门脉高压、肝功能不全等多种因素共同影响发展而成的。因存在肝硬化的基础,肝源性溃疡的治疗除抗溃疡治疗外,还需考虑原发病的治疗,治疗上存在一定的难度。本文结合国内外的研究结果,对肝源性溃疡的发病机制及药物治疗特点予以综述。
    • 摘要: 我患有早期肝硬化,半个月前我的食欲减退,同时出现反酸、嗳气、恶心等症状。到医院做胃镜检查为胃粘膜浅表性糜烂及溃疡,被诊断为肝源性溃疡。请问,我该如何进行治疗?
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号